Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Erectile dysfunction in a primary care setting: results of an observational, no-control-group, prospective study with sildenafil under routine conditions of use

International Journal of Impotence Research volume 13, pages 338–347 (2001)Cite this article

Abstract

In order to assess the effectiveness of sildenafil under routine conditions of use in primary care settings and to evaluate its impact on patient's life satisfaction and partner's satisfaction with treatment for erectile dysfunction (ED), an open, multicentre, observational, prospective study was designed in which 2816 patients were treated with sildenafil for at least 10 weeks. Effectiveness was assessed using the International Index of Erectile Dysfunction (IIEF), life satisfaction was measured with ‘Life-satisfaction Check List’ (LISAT 8), and EDITS was optionally used to assess the partner's satisfaction with ED therapy. Sildenafil was effective in 86.6% of patients. All dimensions of IIEF significantly increased with sildenafil, particularly erectile domain which overall sample mean score improved was 13.2 points (P<0.001). The greatest increases in satisfaction with all aspects of life were seen in sex life and relationship with partner dimensions. The patients' partners, answered by a minority of partners, were highly satisfied with the treatment and its rapid action, therefore they were in favour of continuing with same. The adverse events occurring were similar to those seen in clinical research on sildenafil in the premarketing phase. No control group was included in this study.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. NIH Consensus Development Panel of Impotence. . Impotence. JAMA 1993 270, 83–90.

    Article  Google Scholar 

  2. Montague DK et al. Clinical guidelines panel of erectile dysfunction: summary report on the treatment of organic erectile dysfunction. J Urol 1996 156, 2007–2011.

    Article  CAS  Google Scholar 

  3. Feldman HA et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994 151, 54–61.

    Article  CAS  Google Scholar 

  4. Martín-Morales A et al. Prevalence and independent risk factors for erectile dysfunction in Spain: results of the ‘Epidemiología de la Disfunción Eréctil Masculina’ Study. J Urol 2001 166, 569–574.

    Article  Google Scholar 

  5. Foreman MM, Doherty PC. . Experimental approaches to the development of pharmacological therapies for erectile dysfunction. In: Riley AJ, Peet M, Wilson CA, eds. Sexual Pharmacology Oxford Medical Publications: Oxford 1993 87–113.

    Google Scholar 

  6. Riley AJ, Athanasiadis L. . Impotence and its non-surgical management. Br J Clin Pract 1997 51, 99–105.

    CAS  PubMed  Google Scholar 

  7. Langtry HD, Markham A. . Sildenafil. A review of its use in erectile dysfunction. Drugs 1999 57, 967–989.

    Article  CAS  Google Scholar 

  8. Boolell M, Gepi-Attee S, Gingell JC, Allen MJ. . Sildenafil, a novel effective oral therapy for male erectile dysfunction. Br J Urol 1996 78, 257–261.

    Article  CAS  Google Scholar 

  9. Conte HR. . Development and use of self-reported techniques for assessing sexual functioning: a review and critique. Arch Sex Behav 1983 12, 555–576.

    Article  CAS  Google Scholar 

  10. Andersen BL, Broffit B. . Is there a reliable and valid self-report measure of sexual behavior? Arch Sex Behav 1988 17, 509–525.

    Article  CAS  Google Scholar 

  11. Stewart AL, Ware JE, eds. . Measuring function and well-being: The Medical Outcomes Study Approach. Duke University Press: Durhan and London 1992.

  12. Rosen RC et al. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997 49, 822–830.

    Article  CAS  Google Scholar 

  13. Cappelleri JC et al. Some developments on the International Index of Erectile function (IIEF). Drug Info J 1999 33, 179–190.

    Article  Google Scholar 

  14. Jonler M et al. The effect of age, ethnicity and geographical location on impotence and quality of life. Br J Urol 1995 75, 651–655.

    Article  CAS  Google Scholar 

  15. Fugl-Meyer AR, Lodnert G, Bräholm IB, Fugl-Meyer KS. . On life satisfaction in male erectile dysfunction. Int J Impot Res 1997 9, 141–148.

    Article  CAS  Google Scholar 

  16. Fugl-Meyer AR, Bräholm IB, Fugl-Meyer KS. . Happiness and domain-specific life satisfaction in adult northern Swedes. Clin Rehab 1991 5, 25–33.

    Article  Google Scholar 

  17. Althof SE et al. EDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction. Urology 1999 53, 793–799.

    Article  CAS  Google Scholar 

  18. Morales A, Mishra A, Conway K. . Cross-cultural adaptation of the International Index of Erectile Function (IIEF). Latin American Branch of the International Society for Impotence Research. Annual Meeting 1997 Linares, Chile.

  19. Guyat GH, Juniper EJ, Walter SD. . Interpreting treatment effects in randomised trials. Br Med J 1998 316, 690–693.

    Article  Google Scholar 

  20. Jacobson NS, Truax P. . Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991 59, 12–19.

    Article  CAS  Google Scholar 

  21. Fava M et al. An open trial of oral sildenafil in antidepressant-induced sexual dysfunction. Psychother Psychosom 1998 67, 328–331.

    Article  CAS  Google Scholar 

  22. Hargreave TB. . Efficacy of sildenafil in the treatment of erectile dysfunction in patients with depression. Congress of the Collegium Internationale Neuro-Psychopharmacologicum 1998.

  23. Feldman R, Waterbury CT and the Sildenafil Study Group. . Sildenafil in the treatment of erectile dysfunction: efficacy in patients taking concomitant antihypertensive therapy (abstract). Am J Hypertension 1998 11, Pt 2, 10.

    Article  Google Scholar 

  24. Wicker PA, Sweeney M. . Effect of oral sildenafil on intercourse success in patients with erectile dysfunction of broad-spectrum etiology. American Psychiatric Association, Annual Meeting May 1998.

  25. Hultling C et al. and the Sildenafil Study Group.. Effect of sildenafil (Viagra) on quality of life in men with erectile dysfunction (ED) caused by traumatic spinal cord injury (SCI). Int J Impot Res 1998 10(Suppl 3), S32.

    Google Scholar 

  26. Rendell MS, Rajfer J, Wicker PA, Smith M, for the Sildenafil Study Group. . Sildenafilo en el tratamiento de la disfunción eréctil en varones diabéticos. Un estudio controlado aleatorizado. JAMA (ed. española) 1999 8, 313–321.

    Google Scholar 

  27. Price D. . Sildenafil (Viagra): efficacy in the treatment of erectile dysfunction (ED) in patients with common concomitant conditions. 8th World Meeting on Impotence Research. Int J Impot Res 1998 10(Suppl 3), S34.

    Google Scholar 

  28. Goldstein I et al. Oral Sildenafil in the treatment of erectile dysfunction. New Engl J Med 1998 38, 1397–1404.

    Article  Google Scholar 

  29. Kloner RA, Brown M, Prisant LM, Collins M for the Sildenafil Study Group. . Effect of sildenafil in patients with erectile dysfunction taking antihypertensive therapy. Am J Hypertension 2001 14, 70–73.

    Article  CAS  Google Scholar 

  30. Sadovsky R, Miller T, Moskowitz M, Hackett G. . Three-year update of sildenafil citrate (Viagra®) efficacy and safety. Int J Clin Pract 2001 55, 115–128.

    CAS  PubMed  Google Scholar 

  31. Shakir S, Freemantle S, Pearce G. . IHD morbidity and mortality in a community-based cohort of sildenafil users in England: Phase 1 results. 8th Annual Meeting European Society of Pharmacovigilance. 2000 Verona, Italy.

  32. Araujo AB et al. The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study. Psychosom Med 1998 60, 458–465.

    Article  CAS  Google Scholar 

  33. Kennedy SH, Dickens SE, Eisfeld BS, Bagby RM. . Sexual dysfunction before antidepressant therapy in major depression. J Affec Dis 1999 56, 201–208.

    Article  CAS  Google Scholar 

  34. Shabsigh R et al. Increased incidence of depressive symptoms in men with erectile dysfunction. Urology 1998 52, 848–852.

    Article  CAS  Google Scholar 

  35. Seymour W. . Intimate activities: sexuality. In: Seymour W, ed. Remaking the Body: Rehabilitation and Change Routledge: London 1998 131.

    Google Scholar 

  36. Rosen RC. . Quality of life assessment in sexual dysfunction trials. Int J Impot Res 1998 10(Suppl 2), 521–523.

    Google Scholar 

  37. Cappelleri JC, Rosen RC, Quirk F for the Sildenafil Study Group. . Viagra® (sildenafil citrate) improves quality of life in erectile dysfunction. American Psychological Association, annual meeting August 1998.

  38. Wagner TH, Patrick DL, McKenna SP, Froese PS. . Cross-cultural development of a quality of life measure for men with erection difficulties. Quality of Life Res 1996 5, 443–449.

    Article  CAS  Google Scholar 

  39. Quirk F et al. Effect of Sildenafil (Viagra®) on quality of life parameters in men with broad spectrum erectile dysfunction. J Urol 1998 159(Suppl), 260.

    Google Scholar 

  40. Willke RJ et al. Quality of life effects of Alprostadil therapy for erectile dysfunction. J Urol 1997 157, 2124–2128.

    Article  CAS  Google Scholar 

  41. Young S, on behalf of the Sildenafil Study Group. . Women's perceptions of the efficacy of sildenafil (Viagra®) in the treatment of erectile dysfunction (abstract). British Congress of Obstetrics & Gynaecology 1998 105(Suppl 17), 126.

    Google Scholar 

  42. Hultling C. . Partner's perceptions of the efficacy of sildenafil (Viagra®) in the treatment of erectile dysfunction (abstract no 246). Int J Impot Res 1998 10, S32.

    Google Scholar 

Download references

Acknowledgements

We should like to sincerely thank all the primary care physicians who have participated in this study for the effort made in the follow-up and data collection, without whose help and devotion, this research project would not have been possible.

This research was supported by a restricted grant from Pfizer SA, Spain.

Author information

Authors and Affiliations

  1. Department of Health Sciences, University Rey Juan Carlos, Alcorcón, Madrid, Spain

    A Gil, E Martínez & I Oyagüez

  2. Medical Division and Health Outcomes Research, Medical Division, Pfizer, Madrid, Spain

    G Palacios & J Rejas

Authors
  1. A Gil
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E Martínez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I Oyagüez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G Palacios
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J Rejas
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gil, A., Martínez, E., Oyagüez, I. et al. Erectile dysfunction in a primary care setting: results of an observational, no-control-group, prospective study with sildenafil under routine conditions of use. Int J Impot Res 13, 338–347 (2001). https://doi.org/10.1038/sj.ijir.3900782

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijir.3900782

Keywords

This article is cited by

Search

Advanced search

Quick links